1. Hanusch Hospital and L. Boltzmann Cluster Oncology, Vienna, Austria;
2. L. Boltzmann Institute for Leukemia Research, Vienna, Austria;
3. Hospital Universitario La Fe, Valencia, Spain;
4. Georg August Universität, Göttingen, Germany;
5. The University of Texas MD Anderson Cancer Center, Houston, TX;
6. Institut de Recerca contra la Leucèmia Josep Carreras, Barcelona, Spain;
7. James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY;
8. St James’s University Hospital, Leeds, United Kingdom;
9. Hopital Avicenne, Assistance Publique–Hopitaux de Paris (AP-HP)/University of Paris XIII, Bobigny, France;
10. Hopital Cochin, AP-HP, University of Paris V, Paris, France;
11. Heinrich-Heine University Hospital, Düsseldorf, Germany;
12. Fondazione Istituti di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo and University of Pavia, Pavia, Italy;
13. Institute of Hematology and Blood Transfusion, Praha, Czech Republic;
14. Medical University of Vienna, Vienna, Austria;
15. University of Chicago Comprehensive Cancer Research Center, Chicago, IL;
16. Department of Pathology, University of New Mexico, Albuquerque, NM;
17. Antonio e Biagio e Cesare Arrigo Hospital, Alessandria, Italy;
18. University of Freiburg Medical Center, Freiburg, Germany;
19. Cleveland Clinic, Cleveland, OH;
20. Elisabethinen Hospital, Linz, Austria;
21. Federal University of Ceara, Fortaleza, Brazil;
22. Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan;
23. Division of Hematology, Medical University of Vienna, Vienna, Austria;
24. University Hospital of Innsbruck, Innsbruck, Austria;
25. University of Dundee, Dundee, United Kingdom;
26. Division of Hematology, Medical University of Vienna and L. Boltzmann Cluster Oncology, Vienna, Austria;
27. Hospital Universitario Vall d’Hebron, Barcelona, Spain;
28. Vrije Universiteit Medical Center, Amsterdam, The Netherlands; and
29. Stanford Cancer Institute, Stanford, CA